Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)

Pokaži ostale verzije (1)

Bibliografski detalji
Glavni autori:	Sandham, D, Chen, W, Hardman, C, Luo, J, Xue, L, Ogg, G, Erpenbeck, V
Format:	Conference item
Jezik:	English
Izdano:	Wiley 2019

Slični predmeti

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
od: Chen, W, i dr.
Izdano: (2018)

Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
od: Xue, L, i dr.
Izdano: (2018)

Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
od: Hardman, C, i dr.
Izdano: (2019)

Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
od: Xue, L, i dr.
Izdano: (2019)

IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent
od: Hardman, CS, i dr.
Izdano: (2021)

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells
od: Xue, L, i dr.
Izdano: (2013)

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells.
od: Xue, L, i dr.
Izdano: (2014)

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
od: Ogg, G, i dr.
Izdano: (2015)

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
od: Salimi, M, i dr.
Izdano: (2015)

Role of Mast Cells and Type 2 Innate Lymphoid (ILC2) Cells in Lung Transplantation
od: Esmaeil Mortaz, i dr.
Izdano: (2018-01-01)

Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells
od: Luo, J, i dr.
Izdano: (2019)

Group 2 Innate Lymphoid Cells (ILC2) Suppress Beneficial Type 1 Immune Responses During Pulmonary Cryptococcosis
od: Markus Kindermann, i dr.
Izdano: (2020-02-01)

Innate Lymphoid Cells (ILCs) as Mediators of Inflammation, Release of Cytokines and Lytic Molecules
od: Noha Mousaad Elemam, i dr.
Izdano: (2017-12-01)

Monitoring Cellular Movement with Photoconvertible Fluorescent Protein and Single-Cell RNA Sequencing Reveals Cutaneous Group 2 Innate Lymphoid Cell Subtypes, Circulating ILC2 and Skin-Resident ILC2
od: Minori Nakatani-Kusakabe, i dr.
Izdano: (2021-09-01)

CD1a presentation of endogenous antigens by group 2 innate lymphoid cells
od: Hardman, C, i dr.
Izdano: (2017)

Cysteinyl leukotriene E4 activates human ILC2s and enhances the effect of prostaglandin D2 and epithelial cytokines
od: Salimi, M, i dr.
Izdano: (2017)

Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma
od: Veit J. Erpenbeck, i dr.
Izdano: (2016-12-01)

The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation
od: Christian Domingo, i dr.
Izdano: (2018-09-01)

Group 2 innate lymphoid cells and asthma
od: Hiroki Kabata, i dr.
Izdano: (2015-07-01)

Immunoregulatory Sensory Circuits in Group 3 Innate Lymphoid Cell (ILC3) Function and Tissue Homeostasis
od: Rita G. Domingues, i dr.
Izdano: (2020-02-01)

Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial
od: Gonem, S, i dr.
Izdano: (2016)

Prostaglandin E2 Inhibits Group 2 Innate Lymphoid Cell Activation and Allergic Airway Inflammation Through E-Prostanoid 4-Cyclic Adenosine Monophosphate Signaling
od: Yu Zhou, i dr.
Izdano: (2018-03-01)

Innate lymphoid cell (ILC) subsets are enriched in the skin of patients with hidradenitis suppurativa
od: Andreea Petrasca, i dr.
Izdano: (2023-01-01)

Innate lymphoid cell (ILC) subsets are enriched in the skin of patients with hidradenitis suppurativa.
od: Andreea Petrasca, i dr.
Izdano: (2023-01-01)

Evaluation of Innate Lymphoid Cells (ILCs) Population in the Mouse Model of Colorectal Cancer
od: Seyed Mohammad Javadzadeh, i dr.
Izdano: (2022-12-01)

ILC-You in the Thymus: A Fresh Look at Innate Lymphoid Cell Development
od: Samuel B. Shin, i dr.
Izdano: (2021-05-01)

Testosterone Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation
od: Jacqueline-Yvonne Cephus, i dr.
Izdano: (2017-11-01)

Prostaglandin D2 receptor 2 downstream signaling and modulation of type 2 innate lymphoid cells from patients with asthma.
od: Christina Gress, i dr.
Izdano: (2024-01-01)

Group 2 Innate Lymphoid Cells in Allergic Rhinitis
od: Wang S, i dr.
Izdano: (2024-11-01)

Group 2 innate lymphoid cells and their surrounding environment
od: Maiko Naito, i dr.
Izdano: (2023-03-01)

Group 2 innate lymphoid cells in human asthma
od: Arifumi Iwata, i dr.
Izdano: (2023-04-01)

The Fate of Activated Group 2 Innate Lymphoid Cells
od: Laura Mathä, i dr.
Izdano: (2021-04-01)

Increased circulating innate lymphoid cell (ILC)1 and decreased circulating ILC3 are involved in the pathogenesis of Henoch-Schonlein purpura
od: Lili Zhang, i dr.
Izdano: (2022-04-01)

IL-33-induced keratoconjunctivitis is mediated by group 2 innate lymphoid cells in mice
od: Yuka Hosotani, i dr.
Izdano: (2023-04-01)

The Functional Role of Group 2 Innate Lymphoid Cells in Asthma
od: Takahiro Matsuyama, i dr.
Izdano: (2023-05-01)

Tissue Resident and Migratory Group 2 Innate Lymphoid Cells
od: Laura Mathä, i dr.
Izdano: (2022-04-01)

Group 2 Innate Lymphoid Cells in Respiratory Allergic Inflammation
od: Sofia Helfrich, i dr.
Izdano: (2019-06-01)

The Regulation of the IL-18 on Group 2 Innate Lymphoid Cells in Allergic Rhinitis
od: Chuling Li, i dr.
Izdano: (2021-09-01)

The role of type 2 innate lymphoid cells in the pathogenesis of atopic dermatitis
od: Salimi, M, i dr.
Izdano: (2014)

The roles of type 2 cytotoxic T cells in inflammation, tissue remodeling, and prostaglandin (PG) D2 production are attenuated by PGD2 receptor 2 antagonism
od: Chen, W, i dr.
Izdano: (2021)